July 30, 2014 10:36 PM ET

Healthcare Providers and Services

Company Overview of Health Diagnostic Laboratory, Inc.

Company Overview

Health Diagnostic Laboratory, Inc., a clinical laboratory, provides general and specialty laboratory testing services. The company focuses on disease state management with supporting clinical laboratory testing targeting patients with cardiovascular disease, heart failure, stroke, diabetes mellitus, metabolic syndrome, and nonalcoholic steatohepatitis or fatty liver disease. It offers general and specialty laboratory testing, disease state management and health improvement programs, and specimen handling services, as well as Web based patient portals. The company also provides blood testing services; and support tools for practitioners/physicians to make personalized plans of care for their ...

737 North 5th Street

Suite 103

Richmond, VA 23219-1551

United States

Founded in 2008





Key Executives for Health Diagnostic Laboratory, Inc.

Chief Financial officer
Compensation as of Fiscal Year 2014.

Health Diagnostic Laboratory, Inc. Key Developments

Corgenix Medical Corp. Announces Strategic Partnership with Health Diagnostic Laboratory, Inc. for the Development of a Clinical Laboratory Developed Test

Corgenix Medical Corp. has announced a strategic partnership with Health Diagnostic Laboratory, Inc. (HDL, Inc.) for the development of a clinical Laboratory Developed Test (LDT). The LDT would be based on Corgenix' patented proprietary atherosclerosis biomarker technology for potential use in assessing heart disease risk. Under terms of the multi-year agreement, HDL, Inc. has the rights to use Corgenix technology to develop, validate and offer a clinical LDT that may assist clinicians in predicting an increased risk for heart disease in various patient populations. The initial term of the agreement is three years, with annual renewals thereafter based on certain performance requirements.

GeneNews Limited Enters into Joint Venture to Establish US CLIA Lab

GeneNews Limited announced that it has formed a joint venture with two private American companies, Health Diagnostic Laboratory, Inc. and a sales organization with national capabilities, to establish an accredited clinical laboratory called Innovative Diagnostic Laboratory, LLP. IDL will initially focus on the development and broader US commercialization of ColonSentry and is expected to be functional and certified under the Clinical Lab Improvement Amendments Act ("CLIA") in the third quarter. GeneNews has granted IDL an exclusive license for certain technology related to the ColonSentry test for immediate development and commercialization throughout the United States, excluding the States of New York and New Jersey.

Health Diagnostic Laboratory, Inc. Launches New Blood Test for Stratifying Prediabetic Patients

Health Diagnostic Laboratory, Inc. has launched a new blood test for stratifying prediabetic patients based on the Quantose insulin resistance markers discovered by Metabolon. Insulin resistance is a primary risk factor for type 2 diabetes and cardiovascular complications, and the Quantose biomarkers have been incorporated into HDL's newly launched Diabetes Prevention & Management Panel, or DPMP. The Quantose biomarkers are novel metabolites detected in blood that reflect insulin resistance and detect progression to prediabetes and diabetes earlier than traditional glycemic measures such as HbA1c. By considering insulin resistance, metabolites provide clinicians with a useful tool that goes beyond traditional measures to stratify patients based on their risk for developing diabetes. The Quantose markers are particularly useful in identifying prediabetic patients at the greate risk of disease progression where drug or other interventional therapy may be appropriate.

Similar Private Companies By Industry

Company Name Region
Union Imaging Associates, Inc. United States
Columbus AIDS Task Force Inc. United States
Cottonwood De Tucson, Inc. United States
Magellan Behavioral Health Services, Inc. United States
Cardiac Management Systems, Inc. United States

Recent Private Companies Transactions

October 22, 2013
Oncimmune USA, LLC

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Health Diagnostic Laboratory, Inc., please visit www.hdlabinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.